Dr. John Sottery, PhD

Dr. John Sottery is a scientist who is focused on understanding and optimizing human health at a molecular level. He received his B.S. in Chemistry from Bates College (1981) and his PhD in Chemistry from Duke University (1985), where he was honored with the J.T. Adams Chemistry Fellowship. At Procter & Gamble (P&G), Dr. Sottery led the development of new OTC drug technology and played a key role in developing breakthrough products that achieved hundreds of millions of dollars in sales. He was awarded a P&G Competitive Advantage Award in recognition of his groundbreaking work.

Over the last 38 years, Dr. Sottery’s work has resulted in numerous US patents, international patents, scientific presentations, and publications. He has been an invited speaker at a number of prestigious scientific conferences around the world (Orlando, Cleveland, New York, London, Cannes, Sydney, etc.) including an Invited Keynote Presentation at Formula III in La Grande Motte, France, chaired by the 1991 Nobel Prize Winner, Pierre-Gilles de Gennes. Dr. Sottery has been an expert speaker at the US Food and Drug Administration (FDA) and has been interviewed by numerous publications including Scientific American, GCI and HBW Insight. His educational programs, across the United States, Europe and Australia, have attracted participants from 16 countries.

Dr. Sottery is currently focused on helping individuals understand many of the critical health breakthroughs of the last decade, so they can take a collaborative approach with their healthcare providers to improve their health, vitality, and longevity (by improving their key biochemical markers of health). He is a member of the Phi Lambda Upsilon Honorary Chemical Society, the American Chemical Society, and the Personal Care Products Council.